LCD 200mg/50mg Tablet CR
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Levodopa (200mg) + Carbidopa (50mg)
Overview LCD 200mg/50mg Tablet CR
Parkinson's disease is effectively managed using LCD 200mg/50mg CR tablets, a dual-medication formulation. This treatment significantly alleviates common symptoms like tremors, rigidity, and mobility issues. While this medication can be taken regardless of food intake, minimizing high-protein foods and dairy is recommended. For consistent therapeutic levels, maintain a regular daily dosage schedule. Always adhere to your physician's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Complete the full course of treatment, even with symptom improvement, and discontinue only under medical guidance as abrupt cessation can be detrimental. Potential side effects include nausea, vomiting, dry mouth, sweating, and headaches. Initially, postural hypotension may occur; rise slowly from a seated or lying position. Drowsiness and dizziness are also possible; avoid driving or mentally demanding tasks until the medication's effects are known. Patients with liver or kidney disease should exercise caution and inform their doctor of all other medications being used, as interactions may affect efficacy. Pregnant women, those planning pregnancy, and breastfeeding mothers must consult their physician.
Primary Ingredients of LCD 200mg/50mg Tablet CR
The provided text is "undefined," therefore no rewriting is possible.
Uses of LCD 200mg/50mg Tablet CR
Managing Parkinson's disease
Major Benefits of LCD 200mg/50mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The 200mg/50mg LCD Tablet CR should be swallowed whole; do not crush, chew, or break it. Administer this medication on an empty stomach. High-protein foods, including dairy products like cottage cheese and Swiss cheese, protein supplements, eggs, and milk, should be avoided while taking LCD 200mg/50mg Tablet CR.
Common Side effects of LCD 200mg/50mg Tablet CR:
- Dryness in mouth
- Dizziness
- Headache
- Abnormal dreams
- Involuntary muscle movement
- Gastrointestinal disturbance
- Sweating
How to use LCD 200mg/50mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or fracture it. The LCD 200mg/50mg Tablet CR should be taken on an empty stomach. Refrain from consuming LCD 200mg/50mg Tablet CR with protein-rich foods, including dairy products like cottage cheese and Swiss cheese, protein supplements, eggs, and milk.
How LCD 200mg/50mg Tablet CR works:
The controlled-release tablet, LCD 200mg/50mg CR, combines levodopa and carbidopa to manage Parkinson's disease symptoms. Levodopa, a dopamine precursor, is transformed into dopamine within the brain, a neurotransmitter crucial for motor control. Carbidopa, acting as a peripheral decarboxylase inhibitor, safeguards levodopa from premature degradation, ensuring its efficient delivery to the brain and boosting dopamine concentrations.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and LCD 200mg/50mg CR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release LCD 200mg/50mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The extended-release LCD 200mg/50mg tablet is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant. While some women taking LCD 200mg/50mg Tablet CR experienced partial or complete lactation suppression, breastfeeding resumed after treatment cessation.
DrivingUNSAFE
Driving ability may be impaired by LCD 200mg/50mg Tablet CR, a medication that can induce side effects such as dizziness, drowsiness, and blurred vision, all of which can hinder reaction time.
KidneySAFE IF PRESCRIBED
The extended-release LCD 200mg/50mg tablet is likely safe for individuals with impaired renal function. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using LCD 200mg/50mg Tablet CR. Dosage modification of LCD 200mg/50mg Tablet CR may be necessary. Physician consultation is advised.
What if you forget to take LCD 200mg/50mg Tablet CR :
For omitted LCD 200mg/50mg CR tablets, take the missed dose immediately if you remember. If it's nearly time for your next scheduled dose, however, omit the forgotten dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About LCD 200mg/50mg Tablet CR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
3,018 People bought this recently